Capecitabine/Oxaliplatin/Tislelizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of capecitabine, oxaliplatin, and tislelizumab that may be used in the treatment of esophageal and esophagogastric junction cancers, and gastric cancer.

**Synonyms:** - CapeOx Plus Tislelizumab - CapeOx Plus Tislelizumab-jsgr - CapeOx/Tevimbra - CapeOx/Tislelizumab - CapeOx/Tislelizumab-jsgr - Capecitabine-Oxaliplatin-Tislelizumab - Capecitabine/Oxaliplatin Plus Tislelizumab-jsgr - Capecitabine/Oxaliplatin/Tevimbra - Capecitabine/Oxaliplatin/Tislelizumab - Capecitabine/Oxaliplatin/Tislelizumab-jsgr Regimen